These evidences suggest that GDF15-GFRAL-RET is a central regulator of feeding and body weight and a new therapeutic target of both anorexia-cachexia and obesity (14, 36, 37). This evidence concerns the gene RET and obesity due to melanocortin 4 receptor deficiency.